| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.048 | 0.4 |